Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The antiinflammatory IgG.

× No keyword cloud information.

25 in total

1. Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain-Barré syndrome patients.

Authors: Mohan S Maddur; Magalie Rabin; Pushpa Hegde; Francis Bolgert; Moneger Guy; Jean-Michel Vallat; Laurent Magy; Jagadeesh Bayry; Srini V Kaveri
Journal: Immunol Res Date: 2014-12 Impact factor: 2.829

Review 2. Polyvalent immunoglobulins: challenges and perspectives.

Authors: Isabella Quinti; Serelina Coluzzi; Federica Pulvirenti; Alessandro Prezzo; Gabriella Girelli
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

3. sHLA-I Contamination, a novel mechanism to explain ex vivo/in vitro modulation of IL-10 synthesis and release in CD8(+) T lymphocytes and in neutrophils following intravenous immunoglobulin infusion.

Authors: Massimo Ghio; Paola Contini; Maurizio Setti; Gianluca Ubezio; Clemente Mazzei; Gino Tripodi
Journal: J Clin Immunol Date: 2010-02-02 Impact factor: 8.317

Review 4. Intravenous immunoglobulins--understanding properties and mechanisms.

Authors: A Durandy; S V Kaveri; T W Kuijpers; M Basta; S Miescher; J V Ravetch; R Rieben
Journal: Clin Exp Immunol Date: 2009-12 Impact factor: 4.330

5. Long-term therapy with intravenous immunoglobulin is beneficial in patients with autoimmune diseases.

Authors: Gisele Zandman-Goddard; Alexander Krauthammer; Yair Levy; Pnina Langevitz; Yehuda Shoenfeld
Journal: Clin Rev Allergy Immunol Date: 2012-04 Impact factor: 8.667

Review 6. Intravenous immunoglobulin therapy in rheumatic diseases.

Authors: Jagadeesh Bayry; Vir Singh Negi; Srini V Kaveri
Journal: Nat Rev Rheumatol Date: 2011-05-10 Impact factor: 20.543

Review 7. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy.

Authors: S V Kaveri; M S Maddur; P Hegde; S Lacroix-Desmazes; J Bayry
Journal: Clin Exp Immunol Date: 2011-06 Impact factor: 4.330

8. FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.

Authors: Sudhir Gupta; Sudhanshu Agrawal; Sastry Gollapudi; Hiromi Kubagawa
Journal: Hum Immunol Date: 2016-10-14 Impact factor: 2.850

Review 9. Immunomodulatory therapies in neurologic critical care.

Authors: Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal: Neurocrit Care Date: 2009-09-23 Impact factor: 3.210

Review 10. Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury.

Authors: Tanya N Mayadas; George C Tsokos; Naotake Tsuboi
Journal: Circulation Date: 2009-11-17 Impact factor: 29.690